Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1992 Nov;68(805):857–866. doi: 10.1136/pgmj.68.805.857

An update on nitrate tolerance: can it be avoided?

S R Maxwell 1, M J Kendall 1
PMCID: PMC2399487  PMID: 1494507

Full text

PDF
857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. Hemodynamic effects of nitroglycerin and long-acting nitrates. Am Heart J. 1985 Jul;110(1 Pt 2):216–224. [PubMed] [Google Scholar]
  2. Abrams J. Interval therapy to avoid nitrate tolerance: paradise regained? Am J Cardiol. 1989 Oct 15;64(14):931–934. doi: 10.1016/0002-9149(89)90844-8. [DOI] [PubMed] [Google Scholar]
  3. Agabiti Rosei E., Muiesan M. L., Pollavini G., Bichisao E., Muiesan G. The treatment of angina pectoris with nitroglycerin plasters. A multicenter study involving 6,986 patients. Int J Clin Pharmacol Ther Toxicol. 1987 Oct;25(10):572–581. [PubMed] [Google Scholar]
  4. Atkins J. M. Some issues concerning transdermal nitroglycerin patches. Am Heart J. 1986 Jul;112(1):229–232. doi: 10.1016/0002-8703(86)90712-x. [DOI] [PubMed] [Google Scholar]
  5. Bassan M. M. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate. J Am Coll Cardiol. 1990 Oct;16(4):936–940. doi: 10.1016/s0735-1097(10)80344-4. [DOI] [PubMed] [Google Scholar]
  6. Brügger W., Imhof P., Müller P., Moser P., Reubi F. Effect of nitroglycerin on blood rheology in healthy subjects. Eur J Clin Pharmacol. 1985;29(3):331–336. doi: 10.1007/BF00544090. [DOI] [PubMed] [Google Scholar]
  7. Cowan J. C., Bourke J. P., Reid D. S., Julian D. G. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol. 1987 Aug 1;60(4):271–275. doi: 10.1016/0002-9149(87)90226-8. [DOI] [PubMed] [Google Scholar]
  8. Cowan J. C. Nitrate tolerance. Int J Cardiol. 1986 Jul;12(1):1–19. doi: 10.1016/0167-5273(86)90094-x. [DOI] [PubMed] [Google Scholar]
  9. Crean P. A., Ribeiro P., Crea F., Davies G. J., Ratcliffe D., Maseri A. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial. Am Heart J. 1984 Dec;108(6):1494–1500. doi: 10.1016/0002-8703(84)90697-5. [DOI] [PubMed] [Google Scholar]
  10. Dalal J. J., Parker J. O. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy. Am J Cardiol. 1984 Aug 1;54(3):286–288. doi: 10.1016/0002-9149(84)90184-x. [DOI] [PubMed] [Google Scholar]
  11. Danahy D. T., Aronow W. S. Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation. 1977 Aug;56(2):205–212. doi: 10.1161/01.cir.56.2.205. [DOI] [PubMed] [Google Scholar]
  12. Davidov M. E., Mroczek W. J. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity: a double-blind evaluation. Angiology. 1977 Mar;28(3):181–189. doi: 10.1177/000331977702800306. [DOI] [PubMed] [Google Scholar]
  13. DeMots H., Glasser S. P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989 Mar 15;13(4):786–795. doi: 10.1016/0735-1097(89)90216-7. [DOI] [PubMed] [Google Scholar]
  14. Feelisch M., Noack E. A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 1987 Jul 2;139(1):19–30. doi: 10.1016/0014-2999(87)90493-6. [DOI] [PubMed] [Google Scholar]
  15. Ferratini M., Pirelli S., Merlini P., Silva P., Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. Eur Heart J. 1989 Nov;10(11):998–1002. doi: 10.1093/oxfordjournals.eurheartj.a059425. [DOI] [PubMed] [Google Scholar]
  16. Fung H. L. Pharmacokinetic determinants of nitrate action. Am J Med. 1984 Jun 22;76(6A):22–26. doi: 10.1016/0002-9343(84)91039-8. [DOI] [PubMed] [Google Scholar]
  17. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  18. Geibel A., Meinertz T., Zehender M., Vitak J., Hohnloser S., Kunz-Fritze A., Just H. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study. Eur Heart J. 1989 Sep;10 (Suppl E):81–87. doi: 10.1093/eurheartj/10.suppl_e.81. [DOI] [PubMed] [Google Scholar]
  19. Gruetter C. A., Lemke S. M. Effects of sulfhydryl reagents on nitroglycerin-induced relaxation of bovine coronary artery. Can J Physiol Pharmacol. 1986 Nov;64(11):1395–1401. doi: 10.1139/y86-236. [DOI] [PubMed] [Google Scholar]
  20. Gwilt D. J., Petri M., Reid D. S. Intravenous isosorbide dinitrate in acute left ventricular failure--a dose--response study. Eur Heart J. 1983 Oct;4(10):712–717. doi: 10.1093/oxfordjournals.eurheartj.a061383. [DOI] [PubMed] [Google Scholar]
  21. Hogan J. C., Lewis M. J., Henderson A. H. Chronic administration of N-acetylcysteine fails to prevent nitrate tolerance in patients with stable angina pectoris. Br J Clin Pharmacol. 1990 Oct;30(4):573–577. doi: 10.1111/j.1365-2125.1990.tb03815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hogan J. C., Lewis M. J., Henderson A. H. N-acetylcysteine fails to attenuate haemodynamic tolerance to glyceryl trinitrate in healthy volunteers. Br J Clin Pharmacol. 1989 Oct;28(4):421–426. doi: 10.1111/j.1365-2125.1989.tb03522.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Horowitz J. D., Antman E. M., Lorell B. H., Barry W. H., Smith T. W. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation. 1983 Dec;68(6):1247–1253. doi: 10.1161/01.cir.68.6.1247. [DOI] [PubMed] [Google Scholar]
  24. Ignarro L. J., Degnan J. N., Baricos W. H., Kadowitz P. J., Wolin M. S. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta. 1982 Sep 17;718(1):49–59. doi: 10.1016/0304-4165(82)90008-3. [DOI] [PubMed] [Google Scholar]
  25. Ignarro L. J., Lippton H., Edwards J. C., Baricos W. H., Hyman A. L., Kadowitz P. J., Gruetter C. A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981 Sep;218(3):739–749. [PubMed] [Google Scholar]
  26. Jansen W., Osterspey A., Tauchert M., Schmid G., Schell U., Fuchs M., Hombach V., Hilger H. H. 5-Isosorbidmononitrat unter Ruhe- und Belastungsbedingungen bei koronarer Herzkrankheit. Dtsch Med Wochenschr. 1982 Oct 8;107(40):1499–1506. doi: 10.1055/s-2008-1070155. [DOI] [PubMed] [Google Scholar]
  27. Kala R., Hirvonen P., Gordin A., Sundberg S., Auvinen J., Halonen P. I. Nitroglycerin ointment effective for seven hours in severe angina pectoris. Acta Med Scand. 1983;213(3):165–170. doi: 10.1111/j.0954-6820.1983.tb03711.x. [DOI] [PubMed] [Google Scholar]
  28. Kapoor A. S., Dang N. S., Reynolds R. D. Sustained effects of transdermal nitroglycerin in patients with angina pectoris. Clin Ther. 1985;7(6):674–679. [PubMed] [Google Scholar]
  29. Katz R. J. Mechanisms of nitrate tolerance: a review. Cardiovasc Drugs Ther. 1990 Feb;4(1):247–252. doi: 10.1007/BF01857640. [DOI] [PubMed] [Google Scholar]
  30. Kendall M. J. Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur). J Clin Pharm Ther. 1990 Jun;15(3):169–185. doi: 10.1111/j.1365-2710.1990.tb00373.x. [DOI] [PubMed] [Google Scholar]
  31. Lee G., Mason D. T., De Maria A. N. Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing. Am J Cardiol. 1978 Jan;41(1):82–87. doi: 10.1016/0002-9149(78)90136-4. [DOI] [PubMed] [Google Scholar]
  32. Lis Y., Bennett D., Lambert G., Robson D. A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Med. 1984;10(4):179–184. doi: 10.1007/BF00259434. [DOI] [PubMed] [Google Scholar]
  33. Luke R., Sharpe N., Coxon R. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application. J Am Coll Cardiol. 1987 Sep;10(3):642–646. doi: 10.1016/s0735-1097(87)80208-5. [DOI] [PubMed] [Google Scholar]
  34. May D. C., Popma J. J., Black W. H., Schaefer S., Lee H. R., Levine B. D., Hillis L. D. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med. 1987 Sep 24;317(13):805–809. doi: 10.1056/NEJM198709243171305. [DOI] [PubMed] [Google Scholar]
  35. Miller E. D., Jr, Ackerly J. A., Vaughan E. D., Jr, Peach M. J., Epstein R. M. The renin-angiotensin system during controlled hypotension with sodium nitroprusside. Anesthesiology. 1977 Sep;47(3):257–262. [PubMed] [Google Scholar]
  36. Mittal C. K., Kimura H., Murad F. Purification and properties of a protein required for sodium azide activation of guanylate cyclase. J Biol Chem. 1977 Jun 25;252(12):4384–4390. [PubMed] [Google Scholar]
  37. Muiesan G., Agabiti-Rosei E., Muiesan L., Romanelli G., Pollavini P., Pasotti C., Fiori G., Muratori L., Zuarini A. M., Pastorini C. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration. Am Heart J. 1986 Jul;112(1):233–238. doi: 10.1016/0002-8703(86)90713-1. [DOI] [PubMed] [Google Scholar]
  38. Müller P., Imhof P. R., Burkart F., Chu L. C., Gérardin A. Human pharmacological studies of a new transdermal system containing nitroglycerin. Eur J Clin Pharmacol. 1982;22(6):473–480. doi: 10.1007/BF00609617. [DOI] [PubMed] [Google Scholar]
  39. Nabel E. G., Barry J., Rocco M. B., Mead K., Selwyn A. P. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. Am J Cardiol. 1989 Mar 15;63(11):663–669. doi: 10.1016/0002-9149(89)90248-8. [DOI] [PubMed] [Google Scholar]
  40. Needleman P., Jakschik B., Johnson E. M., Jr Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther. 1973 Nov;187(2):324–331. [PubMed] [Google Scholar]
  41. Needleman P., Johnson E. M., Jr Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973 Mar;184(3):709–715. [PubMed] [Google Scholar]
  42. Nyberg G., Carlens P., Lindström E., Lundman T., Nordlander R., Rehnqvist N., Ulvenstam G., Aberg A., Aström H. The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study. Eur Heart J. 1986 Oct;7(10):835–842. doi: 10.1093/oxfordjournals.eurheartj.a061969. [DOI] [PubMed] [Google Scholar]
  43. Olivari M. T., Carlyle P. F., Levine T. B., Cohn J. N. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. J Am Coll Cardiol. 1983 Nov;2(5):872–878. doi: 10.1016/s0735-1097(83)80234-4. [DOI] [PubMed] [Google Scholar]
  44. Packer M., Lee W. H., Kessler P. D., Gottlieb S. S., Medina N., Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med. 1987 Sep 24;317(13):799–804. doi: 10.1056/NEJM198709243171304. [DOI] [PubMed] [Google Scholar]
  45. Packer M. What causes tolerance to nitroglycerin? The 100 year old mystery continues. J Am Coll Cardiol. 1990 Oct;16(4):932–935. doi: 10.1016/s0735-1097(10)80343-2. [DOI] [PubMed] [Google Scholar]
  46. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  47. Parker J. O. Antianginal efficacy of a new nitroglycerin patch. Eur Heart J. 1989 May;10 (Suppl A):43–49. doi: 10.1093/eurheartj/10.suppl_a.43. [DOI] [PubMed] [Google Scholar]
  48. Parker J. O., Farrell B., Lahey K. A., Moe G. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med. 1987 Jun 4;316(23):1440–1444. doi: 10.1056/NEJM198706043162303. [DOI] [PubMed] [Google Scholar]
  49. Parker J. O., Farrell B., Lahey K. A., Rose B. F. Nitrate tolerance: the lack of effect of N-acetylcysteine. Circulation. 1987 Sep;76(3):572–576. doi: 10.1161/01.cir.76.3.572. [DOI] [PubMed] [Google Scholar]
  50. Parker J. O., Fung H. L., Ruggirello D., Stone J. A. Tolerance to isosorbide dinitrate: rate of development and reversal. Circulation. 1983 Nov;68(5):1074–1080. doi: 10.1161/01.cir.68.5.1074. [DOI] [PubMed] [Google Scholar]
  51. Parker J. O., VanKoughnett K. A., Fung H. L. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy. Am J Cardiol. 1984 Jul 1;54(1):8–13. doi: 10.1016/0002-9149(84)90296-0. [DOI] [PubMed] [Google Scholar]
  52. Popescu L. M., Panoiu C., Hinescu M., Nutu O. The mechanism of cGMP-induced relaxation in vascular smooth muscle. Eur J Pharmacol. 1985 Jan 8;107(3):393–394. doi: 10.1016/0014-2999(85)90269-9. [DOI] [PubMed] [Google Scholar]
  53. Reichek N., Priest C., Zimrin D., Chandler T., Sutton M. S. Antianginal effects of nitroglycerin patches. Am J Cardiol. 1984 Jul 1;54(1):1–7. doi: 10.1016/0002-9149(84)90295-9. [DOI] [PubMed] [Google Scholar]
  54. Rudolph W., Blasini R., Reiniger G., Brügmann U. Tolerance development during isosorbide dinitrate treatment: can it be circumvented? Z Kardiol. 1983;72 (Suppl 3):195–198. [PubMed] [Google Scholar]
  55. Scardi S., Pivotti F., Fonda F., Pandullo C., Castelli M., Pollavini G. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris. Am Heart J. 1985 Sep;110(3):546–551. doi: 10.1016/0002-8703(85)90073-0. [DOI] [PubMed] [Google Scholar]
  56. Schaer D. H., Buff L. A., Katz R. J. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am J Cardiol. 1988 Jan 1;61(1):46–50. doi: 10.1016/0002-9149(88)91302-1. [DOI] [PubMed] [Google Scholar]
  57. Schuster P., Trieb G., Wiechmann H. W. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease. Z Kardiol. 1983;72 (Suppl 3):251–254. [PubMed] [Google Scholar]
  58. Sullivan M., Savvides M., Abouantoun S., Madsen E. B., Froelicher V. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris. J Am Coll Cardiol. 1985 May;5(5):1220–1223. doi: 10.1016/s0735-1097(85)80028-0. [DOI] [PubMed] [Google Scholar]
  59. Thadani U., Fung H. L., Darke A. C., Parker J. O. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 1;49(2):411–419. doi: 10.1016/0002-9149(82)90518-5. [DOI] [PubMed] [Google Scholar]
  60. Thadani U., Hamilton S. F., Olson E., Anderson J., Voyles W., Prasad R., Teague S. M. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct;105(4):485–492. doi: 10.7326/0003-4819-105-4-485. [DOI] [PubMed] [Google Scholar]
  61. Thadani U., Manyari D., Parker J. O., Fung H. L. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar;61(3):526–535. doi: 10.1161/01.cir.61.3.526. [DOI] [PubMed] [Google Scholar]
  62. Thadani U., Whitsett T., Hamilton S. F. Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance. Curr Probl Cardiol. 1988 Nov;13(11):723–784. doi: 10.1016/0146-2806(88)90019-9. [DOI] [PubMed] [Google Scholar]
  63. Waldman S. A., Rapoport R. M., Ginsburg R., Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol. 1986 Oct 15;35(20):3525–3531. doi: 10.1016/0006-2952(86)90622-2. [DOI] [PubMed] [Google Scholar]
  64. Waters D. D., Juneau M., Gossard D., Choquette G., Brien M. Limited usefulness of intermittent nitroglycerin patches in stable angina. J Am Coll Cardiol. 1989 Feb;13(2):421–425. doi: 10.1016/0735-1097(89)90521-4. [DOI] [PubMed] [Google Scholar]
  65. Weber J. R. Recent studies on transdermal nitroglycerin patch efficacy. Am Heart J. 1986 Jul;112(1):238–241. doi: 10.1016/0002-8703(86)90714-3. [DOI] [PubMed] [Google Scholar]
  66. Winniford M. D., Kennedy P. L., Wells P. J., Hillis L. D. Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. Circulation. 1986 Jan;73(1):138–142. doi: 10.1161/01.cir.73.1.138. [DOI] [PubMed] [Google Scholar]
  67. Winsor T., Berger H. J. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design. Am Heart J. 1975 Nov;90(5):611–626. doi: 10.1016/0002-8703(75)90226-4. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES